🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
In this study, participants with high-risk hematologic malignancies undergo...
Status
Completed
Location
St. Jude Children's Research Hospital
Start Date
2013-05-16
Trial ID
NCT01807611
Autologous stem cell therapy has been shown to be effective in patients wit...
Status
Completed
Location
University Hospital Tuebingen; Department of oncology, hematology, rheumatology, immunology and pulmology
Start Date
2012-09
Trial ID
NCT01895244
This is a phase II, single-center study to evaluate the efficacy of a novel...
Status
Completed
Location
Memorial Sloan-Kettering Cancer Center
Start Date
2001-06
Trial ID
NCT00587054
Treatments Being Tested
The MAC-HAPLO-MUD trial is a randomized prospective phase III trial compari...
Status
Unknown
Location
Multiple Locations
Start Date
2018-08
Trial ID
NCT03655145
Treatments Being Tested
This research study is to determine if donor blood stem cells given after l...
Status
Unknown
Location
Stanford University Medical Center
Start Date
2017-02-14
Trial ID
NCT03292445
Treatments Being Tested
CliniMACs is an investigational device used to select and enrich stem cells...
Status
No Longer Available
Location
Dana Farber Cancer Institute
Start Date
2013-03
Trial ID
NCT02026934
Treatments Being Tested
Allogeneic stem cell transplantation (alloSCT) is utilized for various unde...
Status
Available
Location
Multiple Locations
Start Date
TBD
Trial ID
NCT06731036
Treatments Being Tested
Patients with hematologic malignancies will receive myeloablative chemother...
Status
Terminated
Location
Stanford University School of Medicine
Start Date
2009-06
Trial ID
NCT01050764
The purpose of this study is to determine whether a regimen of high-dose im...
Status
Recruiting
Location
Children's Hospital of Pittsburgh of UPMC
Start Date
2018-07-31
Trial ID
NCT03630211
The Stanford Medical Center Division of Immunology and Rheumatology and the...
Status
Terminated
Location
Stanford University School of Medicine
Start Date
2004-06
Trial ID
NCT00325741
Treatments Being Tested